Rebus Holdings, Inc. (RBSH)
0.0000
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Rebus Holdings Cash and Short Term Investments (Quarterly)
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.005M |
| March 31, 2023 | 0.005M |
| December 31, 2022 | 0.005M |
| September 30, 2022 | 0.134M |
| June 30, 2022 | 0.265M |
| March 31, 2022 | 0.587M |
| December 31, 2021 | 0.711M |
| September 30, 2021 | 0.995M |
| June 30, 2021 | 1.13M |
| March 31, 2021 | 0.758M |
| December 31, 2020 | 0.404M |
| September 30, 2020 | 0.033M |
| June 30, 2020 | 0.116M |
| March 31, 2020 | 0.146M |
| December 31, 2019 | 0.023M |
| September 30, 2019 | 0.05M |
| June 30, 2019 | 0.229M |
| March 31, 2019 | 0.276M |
| December 31, 2018 | 0.331M |
| September 30, 2018 | 0.349M |
| June 30, 2018 | 0.004M |
| March 31, 2018 | 0.007M |
| December 31, 2017 | 0.01M |
| September 30, 2017 | 0.018M |
| June 30, 2017 | 0.006M |
| Date | Value |
|---|---|
| March 31, 2017 | 0.033M |
| December 31, 2016 | 0.547M |
| September 30, 2016 | 0.33M |
| June 30, 2016 | 0.926M |
| March 31, 2016 | 1.558M |
| December 31, 2015 | 2.465M |
| September 30, 2015 | 1.24M |
| June 30, 2015 | 0.121M |
| March 31, 2015 | 1.403M |
| December 31, 2014 | 2.316M |
| September 30, 2014 | 3.559M |
| June 30, 2014 | 4.791M |
| March 31, 2014 | 2.576M |
| December 31, 2013 | 3.587M |
| September 30, 2013 | 4.865M |
| June 30, 2013 | 1.50M |
| March 31, 2013 | 2.553M |
| December 31, 2012 | 2.345M |
| September 30, 2012 | 2.550M |
| June 30, 2012 | 3.949M |
| March 31, 2012 | 4.884M |
| December 31, 2011 | 5.530M |
| September 30, 2011 | 6.654M |
| June 30, 2011 | 7.914M |
| March 31, 2011 | 6.750M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |
| Savara, Inc. | 173.03M |
| Vericel Corp. | 162.46M |